Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

ESH 2017 | Balancing hereditary research with patient care in leukemia

Jane Churpek • 5 Oct 2017

ESH 2017

General Leukemia

In recent years, the medical community has become aware of certain genetic factors that can predispose someone to developing hematological malignancies, such as leukemia. However, our understanding of the full extent of the genetic components of these illnesses is far from complete. In this interview, Jane Churpek, MD, of the University of Chicago, Chicago, IL, describes the difficulties faced when treating a patient with leukemia while considering the hereditary aspects of the disease. Dr Churpek highlights some of the typical concerns of patients and the questions that may be asked in this scenario. This video was recorded at the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH).

Updates in classification and risk stratification in MDS

Aziz Nazha et al. • 24 Jun 2022

Role of genetics in hematological malignancies: expanding our understanding

Jane Churpek • 5 Oct 2017

The benefits of patient advocacy groups

Jane Churpek • 5 Oct 2017

Developing an understanding of disease progression in MDS and AML

Jane Churpek • 5 Oct 2017

Related Videos

Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens

Christina Peters • 15 Apr 2024

Pooled fecal allogeneic microbiotherapy to treat refractory gastrointestinal acute GvHD

Florent Malard • 11 Apr 2024

Current and emerging treatment approaches for steroid-refractory acute & chronic GvHD

Mohamad Mohty • 17 Apr 2024

HHV-6 reactivation after haploidentical transplantation with PTCy & ATG: incidence and risk factors

Rémy Duléry • 15 Apr 2024